《Inkef & Dealroom：2022年第三季度健康科技健康科技初创公司与风险投资报告（英文版）（12页）.pdf》由会员分享，可在线阅读，更多相关《Inkef & Dealroom：2022年第三季度健康科技健康科技初创公司与风险投资报告（英文版）（12页）.pdf（12页珍藏版）》请在三个皮匠报告上搜索。

1、Healthtech startups and venture capitalQ3 2022October 2022Page/2 Source:Dealroom.co$4BHealthtech and BiotechGlobal VC funding by industry in Q3 2022VC funding Growth by Industry,Q3 2022 vs.Q3 2021FintechEnergyTransportationMarketingFoodSecurityReal EstateSemiconductor$16.7B$13.4B$10.4B$6.3B$4.9B$4.4

2、B$3.2B$2.7B$2.6BTotal VC Funding+28%+1%-35%-46%-52%-58%-62%-65%-66%-46%SemiconductorEnergyHealthtech and BiotechMarketingReal EstateSecurityFintechTransportationFoodDoneHealthtech and Biotech,together,are the top industry for VC funding globally in Q3 2022.Page/3$4BDoneGlobal healthtech*startups are

3、 now valued at$1.8T.End Q3 2022202120202019201820172016201520142013201220112010$2.0T$1.5T$1.0T$0.5T$1.8T$1.7T$1.1TCombined enterprise value of healthtech startups view onlineby launch yearSource:Dealroom.co.*Healthtech excludes biotech and pharma companies.2015202120102014 20052009 20002004 19951999

4、 19941990Page/4 Healthtech funding in Q3 reached$12B,down 9%compared to Q2 2022 and down 34%vs.Q3 2021.$12B$20B$15B$10B$5BSource:Dealroom.co.$13B$14B$17B$18B$13BGlobal venture capital investment in healthtech startups view online2018Q4Q3Q2Q12019Q4Q3Q2Q12020Q4Q3Q2Q12021Q4Q3Q2Q12022Q3Q2Q1$250m+$100250

5、m$40100m(series C)$1540m(series B)$415m(series A)$14m(seed)$01m(pre-seed)GrowthBreakoutEarlyHealthtech startups who raised the most in Q3 2022 view onlinePage/6$4BDoneThe share of Early-stage rounds(smaller than$15M)increased from 10%to 21%YoY,while the share of rounds above$100M decreased from 55%t

6、o 33%.Source:Dealroom.co.Global venture capital investment in healthtech startups view online2018Q4Q3Q2Q12019Q4Q3Q2Q12020Q4Q3Q2Q12021Q4Q3Q2Q12022Q3Q2Q1100%80%60%40%20%21%17%24%25%8%13%8%22%26%29%$250m+$100250m$40100m(series C)$1540m(series B)$415m(series A)$14m(seed)$01m(pre-seed)GrowthBreakoutEarly